Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACLIZUMAB vs DACTINOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACLIZUMAB vs DACTINOMYCIN: Safety Overview

Metric DACLIZUMAB DACTINOMYCIN
Total FAERS Reports 2,801 2,858
Deaths Reported 193 507
Death Rate 6.9% 17.7%
Hospitalizations 835 721
Average Patient Age 45.7 yrs 18.8 yrs
% Female Patients 81.5% 65.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Eugia US LLC
Route N/A INTRAVENOUS
Marketing Status Prescription Discontinued